A natural, research-backed programme addressing vitiligo at its root — supporting immune balance, melanocyte recovery, and gradual skin repigmentation through our Horus & Tzenova bioactive formulation.
Vitiligo is a chronic autoimmune skin condition in which the immune system attacks melanocytes — the cells responsible for producing skin pigment (melanin). The result is depigmented white patches that can appear anywhere on the body, face, and scalp.
These patches can gradually spread and may merge, affecting larger areas of skin over time. While vitiligo is not contagious or life-threatening, its psychological and emotional impact on those living with it can be profound — affecting self-esteem, social life, and mental wellbeing.
Vitiligo is multifactorial — no single cause explains all cases. Understanding the triggers is essential to designing effective treatment.
The immune system mistakenly attacks and destroys melanocytes — the pigment-producing cells. This is the primary mechanism in most cases of vitiligo.
Vitiligo runs in families. Individuals with a first-degree relative with vitiligo have a higher risk of developing the condition themselves.
Physical trauma to the skin (cuts, burns, sunburn) or severe emotional stress can trigger or accelerate the onset and spread of vitiligo patches.
Excessive sun exposure or sunburn may damage remaining melanocytes, worsening depigmentation in affected areas.
Contact with certain industrial chemicals and some skin care products may damage or destroy melanocytes in susceptible individuals.
Vitiligo is often associated with other autoimmune conditions such as thyroid disorders, type 1 diabetes, and alopecia areata.
At Green Fields Overseas R&D, our scientists identified that vitiligo — as an immune-mediated condition — responds uniquely to a combination of our Horus Formula4 and Tzenova bioactive formulations, working in synergy to address multiple aspects of the condition simultaneously.
Our ongoing observational programme has documented encouraging outcomes — from stabilisation of depigmentation spread to gradual repigmentation over a sustained treatment period.
Tzenova's natural bioactive compounds help regulate the overactive autoimmune response, reducing the rate of ongoing melanocyte destruction.
Horus Formula4's powerful antioxidant and amino acid complex provides the cellular building blocks needed for melanocyte survival and function.
High oxidative stress in the skin accelerates melanocyte death. Our formulas' antioxidant profile actively counteracts this, protecting remaining pigment cells.
Over a sustained programme, some patients have observed gradual return of natural skin colour to previously depigmented areas — particularly around the edges of patches.
Results vary by individual. These are general observations from our ongoing programme — not guaranteed outcomes.
Immune activity begins to regulate. Spread of existing patches may slow or pause. Some patients report reduction in itching or skin sensitivity around patches.
Melanocytes begin to receive the nutritional support they need. Oxidative stress in skin cells reduces. Early repigmentation dots may appear at patch edges.
In responding patients, gradual repigmentation becomes more visible — patches may shrink from edges inward. Skin tone in affected areas begins to return.
Sustained use continues to support skin recovery. Many patients maintain or continue to improve with the programme. Immune resilience is strengthened long-term.
Results vary. This programme is not a cure for vitiligo. These observations are from our R&D programme and patient reports. Always consult a dermatologist for personalised medical advice.
Currently there is no known medical cure for vitiligo. However, treatments including our programme can help stabilise the condition, slow its spread, and in some cases promote repigmentation of affected skin areas.
Yes. Our Horus Formula4 and Tzenova formulations are 100% natural with no known side effects. They are suitable for all skin types and ethnicities. We recommend consulting your healthcare provider if you are pregnant, nursing, or on prescription medication.
Most patients in our programme begin to notice stabilisation (slowing of spread) within the first 4–6 weeks. Visible repigmentation, where it occurs, is typically observed from month 3 onwards. A minimum 6-month commitment is recommended for meaningful assessment.
Please consult a paediatrician before starting children on this programme. Tzenova and Horus Formula4 are generally safe, but dosage adjustments may be appropriate for younger patients.
Many patients use our programme alongside phototherapy (NB-UVB) or topical treatments. Our formulas are natural and generally compatible, but we recommend informing your dermatologist before combining treatments.
Order directly from Green Fields Overseas via WhatsApp (+234 706 267 2130) or by calling us. We ship across Nigeria and can advise on international orders.
Speak directly with our team about the Vitiligo Programme — get personalised guidance, dosage recommendations, and answers to your specific situation.
Your enquiry is private and confidential. We are here to help.
Also discover our other products:
Horus Formula4 — Eye Care Tzenova — Blood Sugar Health PrurX — Mosquito Bite Relief